학술논문
Acute cytokine release syndrome after a first dose of pembrolizumab as second-line treatment for metastatic, programmed death-ligand 1-positive, non-small-cell lung cancer
Document Type
Article
Source
In: Journal of Oncology Pharmacy Practice . (Journal of Oncology Pharmacy Practice, August 2021, 27(6):1528-1533)
Subject
Language
English
ISSN
1477092X
10781552
10781552